Inovio Pharmaceuticals Stock Forecast - Information Ratio

INO Stock  USD 4.07  0.01  0.25%   
Inovio Stock Forecast is based on your current time horizon. Although Inovio Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Inovio Pharmaceuticals' systematic risk associated with finding meaningful patterns of Inovio Pharmaceuticals fundamentals over time.
  
As of the 24th of November 2024, Inventory Turnover is likely to drop to 1.70. In addition to that, Payables Turnover is likely to drop to 0.72. As of the 24th of November 2024, Common Stock Shares Outstanding is likely to grow to about 28 M, though Net Loss is likely to grow to (239.2 M).
Inovio Pharmaceuticals has current Information Ratio of 0.
Check Inovio Pharmaceuticals VolatilityBacktest Inovio PharmaceuticalsInformation Ratio  

Inovio Pharmaceuticals Trading Date Momentum

On November 24 2024 Inovio Pharmaceuticals was traded for  4.07  at the closing time. Highest Inovio Pharmaceuticals's price during the trading hours was 4.22  and the lowest price during the day was  4.04 . There was no trading activity during the period 0.0. Lack of trading volume on the 24th of November did not cause price change. The trading delta at closing time to current price is 0.25% .
Compare Inovio Pharmaceuticals to competition

Other Forecasting Options for Inovio Pharmaceuticals

For every potential investor in Inovio, whether a beginner or expert, Inovio Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Inovio Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Inovio. Basic forecasting techniques help filter out the noise by identifying Inovio Pharmaceuticals' price trends.

Inovio Pharmaceuticals Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Inovio Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Inovio Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Inovio Pharmaceuticals by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Inovio Pharmaceuticals Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Inovio Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Inovio Pharmaceuticals' current price.

Inovio Pharmaceuticals Market Strength Events

Market strength indicators help investors to evaluate how Inovio Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Inovio Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Inovio Pharmaceuticals stock market strength indicators, traders can identify Inovio Pharmaceuticals entry and exit signals to maximize returns.

Inovio Pharmaceuticals Risk Indicators

The analysis of Inovio Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Inovio Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting inovio stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
When determining whether Inovio Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inovio Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inovio Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inovio Pharmaceuticals Stock:
Check out Historical Fundamental Analysis of Inovio Pharmaceuticals to cross-verify your projections.
To learn how to invest in Inovio Stock, please use our How to Invest in Inovio Pharmaceuticals guide.
You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inovio Pharmaceuticals. If investors know Inovio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inovio Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.43)
Revenue Per Share
0.025
Quarterly Revenue Growth
(0.55)
Return On Assets
(0.40)
Return On Equity
(0.91)
The market value of Inovio Pharmaceuticals is measured differently than its book value, which is the value of Inovio that is recorded on the company's balance sheet. Investors also form their own opinion of Inovio Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Inovio Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inovio Pharmaceuticals' market value can be influenced by many factors that don't directly affect Inovio Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inovio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Inovio Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inovio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.